Introduction
Burn is a type of tissue loss caused by heat, electricity, chemical materials, or radiation exposure. Despite lacking a reliable database in Turkey, it is reported that ~11 million people worldwide require medical treatment for burn injuries (1) (2) (3) (4) . Burn injuries are characterized by substantial loss of liquids, electrolytes, proteins, and minerals due to disrupted skin barrier functions. Additionally, ongoing processes (e.g., severe catabolism, infection, and wound healing) are linked to an increased demand for nutrients.
The wound-healing process comprises three main interconnected phases, the exudative or inflammatory phase (3 days), proliferative phase (approximately 10 days), and regenerative phase (approximately 2 years) (5-7). Wound healing aims to minimize tissue damage and ensure sufficient tissue perfusion and oxygenation. During this process, the production of reactive oxygen species is important for preventing infection. However, its excessive production may cause oxidative stress, impeding the wound healing process (8, 9) . Coenzyme Q10 (CoQ10) is a vitamin-like, fatsoluble, antioxidant molecule that is important in the mitochondrial respiratory chain. It promotes tissue healing by reducing oxidative stress and increasing mitochondrial functioning. A study on rats revealed that CoQ10 increases collagen synthesis in wound tissues (10) . Currently, there is an unmet medical need for the effective treatment of burn injury patients, and further studies in this area are warranted. Data from studies investigating the effectiveness of CoQ10 in this setting are limited. Herein, we investigated the effectiveness of topically applied CoQ10 for wound healing in rats with experimentally induced burn injuries.
Materials and Methods
Chemicals: Silver sulfadiazine; Silverdin®, Deva Drug Corporation. Ketamine; Ketalar; Pfizer Drug Corporation. Xylazine; Kepro Xylazine; Biopharm Drug Corporation. CoQ10 (ubiquinol); Solgar Ubiquinol Reduced CoQ10, 100 mg 50 Softgels. Experimental protocol: All rats used in this study were provided from the Animal Research Station of Canakkale Onsekiz Mart University, Turkey. The animals were housed in special metal lattices at room temperature under stable environmental terms (21°C ± 2°C and 12 hour dark-12 hour light cycles). Albino Wistar rats weighing 220-250 g were separated into three groups. All rats were anesthetized with xylazine and ketamine. The back of the rats was shaved under anesthesia, no further intervention was performed. Biopsy samples for histopathologic analysis were obtained from the shaved area under general anesthesia at Days 3 and 10. Subsequently, the rats were sacrificed.
-(Group 2A (Day 3); Group 2B (Day 10); (Silver sulfadiazine group); The back of the rats was shaved under anesthesia, and hot water (95°C) was applied to the shaved area for 10 seconds (Fig. 1) . Subsequently, the rats were wrapped with a cold towel and 8 ml of Ringer's lactate were applied intraperitoneally to avoid burn shock. Silver sulfadiazine was applied topically to the burn wounds daily (Fig. 2) . Biopsy samples for histopathologic analysis were obtained from the injured tissues under general anesthesia at Days 3 and 10. Subsequently, the rats were sacrificed. -Group 3A (Day 3); Group 3B (Day 10); (CoQ10 group); The back of the rats was shaved under anesthesia and hot water (95°C) was applied to the shaved area for 10 seconds. Subsequently, the rats were wrapped with a cold towel, and 8 ml of lactated Ringer's solution were administered intraperitoneally to avoid burn shock. A sterile derivative of CoQ10 10 mg/kg prepared with saline solution was applied topically to the burn wounds daily (Fig. 3) . Biopsy samples for histopathologic analysis were obtained from the injured tissue under general anesthesia at Days 3 and 10. Subsequently, the rats were sacrificed. All groups on the 3 th day, B groups represent biopsies sampled on day 10. Histopathological study: All samples were put into buffered formaldehyde. Samples embedded in paraffin blocks were stained with hematoxylin and eosin (H & E) using 5-6 μm thick sections. Additionally H&E, immunohistochemicaly analyses were done using glutathione S-transferase (GSTP 1), glutathione reductase (Glut-Red), superoxide dismutase (SOD-1), and catalase (CAT). Dako kits and staining device were used to stain 2-4 μm thickness sections from paraffin blocks (Fig. 4-6 ). Parameters such as edema, inflammation, epidermal damage, vascular damage, and collagen damage were evaluated histopathologically ( Table  1) . The effects of the treatment on these parameters were studied using the following scale: 0 = None effect; 1 = Minor effect; 2 = Important effect; 3 = Intense effect. Staining using GSTP-1, CAT Glut Red, and SOD-1 was evaluated using the following scale: 0 = no staining; 1 = weak positivity; 2 = moderate positivity; 3 = strong positivity. Statistical analysis: Data were analyzed using the Statistical Package for Social Sciences version 20, Chicago, IL, USA. Normality of continuous data was determined by the Kolmogorov-Smirnov test. Parametric and non-parametric Mann-Whitney U and Kruskal-Wallis tests were conducted. Data are expressed as means ± standard deviations. Twotailed p values < 0.05 were considered to be statistically significant. The Bonferroni test was used for differences among groups. A p<0.05 point out statistical significance.
Results
The statistical analyses showed that the results of samples from all groups were not normally distributed. Therefore, the Kruskal-Wallis test was used for comparisons. All parameters were valudated using the Mann Whitney U test. The asymptomatic sign value between groups 1A-1B-2A-2B-3A-3B for each parameter was p=0.001 (p<0.05); denoting a statistically significant difference among all groups. P<0.05, pair-group analysis was valuation by the Mann-Whitney U test and each immunohistochemical marker was individually scored. However, statistical valuation was performed for each rat on the basis of the total score. Pair-group analysis: There was a statistically significant difference between group 1 and all other groups in terms of all parameters (edema, inflammation, epidermal damage, vascular damage, and collagen damage). There was no statistically significant difference between the parameters of group 2 and group3. Only in terms of edema, there was a statistically significant difference between the group 3 (CoQ10) at Day 10 and the group 2 (silver sulfadiazine group) at Day 3; and there was a statistically significant difference between the group 3 (CoQ10 group) and the group 2 (silver sulfadiazine group) at Day 10. P-values are summarized in table 2 according to histopathological parameters in study groups ( Table 2) .
Discussion
CoQ10 is an oil-soluble antioxidant used as antiaging and anti-wrinkle agent in cosmetic (7) (8) (9) (10) (11) . Oxygen species are produced in cutaneous injury. Thus it may be beneficial to protect cells from reactive oxygen species-induced damage through improving local antioxidant activity in wounds (10) . It is known that several numerous markers such as matrix metalloproteinases, SOD-1, CAT, reduced (11) (12) (13) . In vitro models for studies investigating experimental burn injuries are limited. Moreover, the use of animal models is essential for this research. Rats are a frequently used animal model for studies investigating experimental burn injuries. Various techniques including direct contact with a heated metal, electricity, and heated water have been used in experimental animal models. Among those, the hot water model is the most commonly used and considered as the standard method for animal models of burn injuries (6) . We implemented the hot water method in this study and it was based on the method described previously by Allgöwer et al, with a slight modification (11) . The CoQ10 is a lipophilic molecule with large molecular weight (14) . Consequently, the efficacy of gastrointestinal administration of CoQ10 is poor. Furthermore, the bioavailability of topical CoQ10 is poor, and new topical formulations such as liposomal CoQ10 have recently been developed to improve bioavailability. Lee and Tsai, using an experimental rat model, reported that topical administration of liposomal CoQ10 improved bioavailability and indicated that penetration of CoQ10 was dependent on concentration (15) . The investigators also found that long-term exposure of skin to CoQ10 resulted in improved skin penetration. In the present study, liposomal CoQ10 was used. Immunohistochemical analysis to determine oxidative stress showed that there was a statistically significant difference between the biopsy samples obtained at Day 10 in terms of GSTP-1, CAT, Glut Red, and SOD-1 activity. Moreover, it was observed that the levels of free oxygen radicals in the biopsies were higher in the CoQ10 group compared with the silver sulfadiazine group. (17) . Damage to the skin triggers edema and inflammatory cell infiltration (18) (19) (20) . This may lead to disruption of the antioxidant balance, damages to cellular proteins and lipids, DNA oxidation, and elevate in the levels of free oxygen radicals at the cellular level (21, 22) . Based on the most parameters evaluated in the present study, CoQ10 was not superior to silver sulfadiazine. This may be due to insufficient penetration of topically applied CoQ10 into the injured tissue or have a short duration (10 days). In conclusion: This investigation did not demonstrate a serious beneficial role of treatment with CoQ10 for the healing of burn wounds. However in the long term (10 days), immunohistochemical analysis performed to determine edema and oxidative stress showed that treatment with CoQ10 reduced the levels of free oxygen radicals in biopsies. The limitation of our study is that the duration is limited to 10 days. 
